|
The Paradigm Link® blood
glucose monitor (left),
developed with Medtronic
for use with a "smart"
Paradigm® insulin pump
(right), won a 2004 Medical
Design Excellence Award. |
 |
 focus on higher value products, combined with
business strategies aimed at growth, is the key driver
behind the faster pace of innovation across BD today. BD
is committed to developing products and systems–in both
insulin delivery and blood glucose monitoring–that will help
improve diabetes management and the quality of life for
those who have diabetes.
BD is working to discover and develop novel approaches
for the future and is teaming with external partners to broaden
its market presence. Today's higher value diabetes management
products are the Paradigm Link® blood glucose monitor and
the BD Logic blood glucose monitor. Significantly, both products
have received clearance from the U.S. Food and Drug
Administration (FDA) for alternate site testing (off-finger),
providing greater convenience for patients when checking
blood glucose levels. Both feature a small sample size and
5-second test time, and the Paradigm Link® monitor is used
with "smart" Paradigm® pumps to greatly simplify the complex
process of managing diabetes. Looking to the future, BD
continues to actively research more advanced approaches to
treating a disease that is spreading at an ever-faster rate, with
the ultimate goal of helping to find a cure.
Strengthening its traditional leadership in insulin delivery,
BD brought to market two new insulin syringes featuring
the thinnest insulin syringe needles available in the U.S.–
the 31-gauge BD Ultra-Fine II Short Needle Insulin Syringe
and the 30-gauge BD Ultra-Fine Needle Insulin Syringe.
The Company also introduced a 1ml version of its BD Integra
syringe, which extends retracting technology to a smaller size
syringe that can be used for insulin delivery in a clinical setting,
as well as other uses.
Renewing its long-term efforts in diabetes education,
BD is working with swimmer Gary Hall, Jr.–the winner of
10 Olympic medals–who has Type 1 diabetes. By teaming
with Hall, BD seeks to inspire people with diabetes and
demonstrate that they can access the insulin injection products
and educational support they need to live healthy lives.
In keeping with new U.S. Environmental Protection Agency
recommendations for the safe home disposal of needles, lancets
and syringes, BD offers the BD Sharps Disposal By Mail
system for safe disposal of used insulin sharps. The BD Sharps
Disposal By Mail system encompasses containment, storage,
transportation, disposal and tracking of sharps, all in one
package. System materials are available in local pharmacies
and include sharps containers, wrapping bags and postage-paid
mailing boxes.
The BD Ultra-Fine II Short Needle Insulin
Syringe is scaled in half-unit markings, allowing
for precise dosage, and offers a short
(8-millimeter) needle. |
At 5 millimeters (316 inch), the BD Ultra-Fine III
Mini Pen Needle is the shortest pen needle in the
world and can be used safely by both children
and adults.
 |
BD Ultra-Fine 33 Lancets are the thinnest
lancets available, an attribute that translates
into low pain for diabetes patients when they
take a blood sample. |
Worldwide, more than
180 million people currently
suffer from diabetes,
including 400,000
children. Poor dietary
habits, obesity and
sedentary lifestyles are
also responsible for
increasing the incidence
of diabetes among
adolescents worldwide.
BD continues to respond
to the needs of people
with diabetes by providing
a wide range of tools
and services to help them
manage their disease. As
one example, in North
America, a recent innovation
is the Paradigm
Link® blood glucose monitor,
powered by BD Logic
technology. It is the first
blood glucose monitor
to provide wireless communication
between a
monitor and Medtronic's
"smart" Paradigm®
insulin pumps. This integrated,
easy-to-use
system simplifies diabetes
management: blood
sugar monitoring and
insulin dosing. |
|
 |
|
|
|
